Literature DB >> 19017689

Asbestosis mortality in the USA: facts and predictions.

V C dos Santos Antao1, G A Pinheiro, J T Wassell.   

Abstract

BACKGROUND: Mortality trends in the USA show that deaths from asbestosis are increasing, while deaths related to other pneumoconiosis are declining.
OBJECTIVES: To analyse the association between asbestos consumption and asbestosis mortality trends.
METHODS: In an epidemiological time series study, we used a modern computer-intensive local regression method to evaluate the relationship between asbestos consumption per capita (1900-2006) as the predictor variable and number of deaths from asbestosis (1968-2004). The predictor variable was progressively lagged by annual increments from 30 to 60 years and the goodness of fit assessed for each lag period. The model having the smallest Akaike's Information Criteria was used to derive extrapolated estimates of future mortality based on more recent asbestos consumption data.
RESULTS: Asbestos consumption per capita reached a peak in 1951 and gradually declined until 1973, when it started to drop rapidly. In 2006, it was 0.0075 kg/person/year. There were 25 564 deaths from asbestosis over the period 1968-2004. The best-fitting model (adjusted coefficient of determination (R(2)) = 99.7%) for 1968-2004 deaths from asbestosis used asbestos consumption per capita 48 years prior (1920-1956) and the log value of asbestos consumption per capita 43 years prior (1925-1961). This model predicts a total of 29 667 deaths (95% CI 19 629 to 39 705) to occur during 2005-2027 (an average of 1290 deaths per year).
CONCLUSIONS: This study demonstrates a clear association between asbestos consumption and deaths from asbestosis and indicates that asbestosis deaths are not expected to decrease sharply in the next 10-15 years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017689     DOI: 10.1136/oem.2008.039172

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  7 in total

1.  UK asbestos imports and mortality due to idiopathic pulmonary fibrosis.

Authors:  C M Barber; R E Wiggans; C Young; D Fishwick
Journal:  Occup Med (Lond)       Date:  2015-10-28       Impact factor: 1.611

2.  Current and future risks of asbestos exposure in the Australian community.

Authors:  Corie Gray; Renee N Carey; Alison Reid
Journal:  Int J Occup Environ Health       Date:  2016-09-09

3.  Diseases attributable to asbestos exposure: years of potential life lost, United States, 1999-2010.

Authors:  Ki Moon Bang; Jacek M Mazurek; John M Wood; Scott A Hendricks
Journal:  Am J Ind Med       Date:  2013-09-20       Impact factor: 2.214

4.  Trends and Patterns of Differences in Chronic Respiratory Disease Mortality Among US Counties, 1980-2014.

Authors:  Laura Dwyer-Lindgren; Amelia Bertozzi-Villa; Rebecca W Stubbs; Chloe Morozoff; Shreya Shirude; Mohsen Naghavi; Ali H Mokdad; Christopher J L Murray
Journal:  JAMA       Date:  2017-09-26       Impact factor: 56.272

5.  Global magnitude of reported and unreported mesothelioma.

Authors:  Eun-Kee Park; Ken Takahashi; Tsutomu Hoshuyama; Tsun-Jen Cheng; Vanya Delgermaa; Giang Vinh Le; Tom Sorahan
Journal:  Environ Health Perspect       Date:  2011-04       Impact factor: 9.031

6.  Asbestos: use, bans and disease burden in Europe.

Authors:  Takashi Kameda; Ken Takahashi; Rokho Kim; Ying Jiang; Mehrnoosh Movahed; Eun-Kee Park; Jorma Rantanen
Journal:  Bull World Health Organ       Date:  2014-09-17       Impact factor: 9.408

7.  National use of asbestos in relation to economic development.

Authors:  Giang Vinh Le; Ken Takahashi; Antti Karjalainen; Vanya Delgermaa; Tsutomu Hoshuyama; Yoshitaka Miyamura; Sugio Furuya; Toshiaki Higashi; Guowei Pan; Gregory Wagner
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.